Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research.

Amount: up to $150,000
Type: Grant

Key facts

Key facts for Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
Amount	up to $150,000
Issuer	National Institutes of Health
Who can apply	Small businesses, companies, universities and 7 more
Sectors	EdTech · HealthTech
Deadline	Closes 11 Aug 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 2 days ago

91 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Cooperative Agreement for affiliated Partner with Alaska Cooperative Ecosystem Studies Unit	up to $234,460	Closes 07 Dec 2026
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit	up to $150,000	Closes 07 Dec 2026